GAL-1A Plus Blood Glucose Monitoring System
K-Number: K213887 · 2022-03-29
Device Summary
Frequently Asked Questions
What is the GAL-1A Plus Blood Glucose Monitoring System?
GAL-1A Plus Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2022-03-29. The listed applicant is Apex BioTechnology Corp.. The 510(k) number is K213887.
When did GAL-1A Plus Blood Glucose Monitoring System receive FDA 510(k) clearance?
GAL-1A Plus Blood Glucose Monitoring System received FDA 510(k) clearance on 2022-03-29, under 510(k) number K213887.
Who is the listed applicant for GAL-1A Plus Blood Glucose Monitoring System?
The FDA 510(k) record lists Apex BioTechnology Corp. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for GAL-1A Plus Blood Glucose Monitoring System?
The FDA product code for GAL-1A Plus Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.
Other records listing Apex BioTechnology Corp. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: NBW)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.